|
C9ORF46 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.154400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.945200E-01 |
| Normal-vs-Stage2 |
3.010800E-01 |
| Normal-vs-Stage3 |
3.443800E-01 |
| Normal-vs-Stage4 |
3.704200E-01 |
| Stage1-vs-Stage2 |
3.724600E-01 |
| Stage1-vs-Stage3 |
2.832000E-01 |
| Stage1-vs-Stage4 |
3.606800E-01 |
| Stage2-vs-Stage3 |
9.398000E-01 |
| Stage2-vs-Stage4 |
7.969800E-01 |
| Stage3-vs-Stage4 |
8.812400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.509000E-01 |
| Normal-vs-AfricanAmerican |
7.744800E-01 |
| Normal-vs-Asian |
9.716400E-01 |
| Caucasian-vs-AfricanAmerican |
4.091400E-01 |
| Caucasian-vs-Asian |
9.335200E-01 |
| AfricanAmerican-vs-Asian |
8.842600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.500800E-01 |
| Normal-vs-Female |
6.107400E-01 |
| Male-vs-Female |
1.748810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.768200E-01 |
| Normal-vs-Extreme_Weight |
8.521600E-01 |
| Normal-vs-Obese |
5.147800E-01 |
| Normal-vs-Extreme_Obese |
4.779400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.509800E-01 |
| Normal_Weight-vs-Obese |
4.397800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.315400E-01 |
| Extreme_Weight-vs-Obese |
6.053800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.540000E-01 |
| Obese-vs-Extreme_Obese |
3.826400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.355500E-04 |
| Normal-vs-Age(41-60Yrs) |
4.206400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.683000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.356000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.026410E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.655840E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.274400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.284600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.743400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.855000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.049200E-01 |
| Normal-VS-Type2 PRCC |
4.548400E-01 |
| Normal-VS-KIRP CIMP |
1.73039999995517E-06 |
| Normal-VS-Unclassified PRCC |
5.905800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.320600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.77710000000598E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.021990E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.12840000005199E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
2.283600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.479900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.135000E-01 |
| Normal-vs-N1 |
9.807600E-04 |
| Normal-vs-N2 |
3.038000E-01 |
| N0-vs-N1 |
3.708100E-02 |
| N0-vs-N2 |
2.945000E-01 |
| N1-vs-N2 |
8.703800E-01 |
|
|
